Smaldone Alsup Laurie
SEC insider (Form 3/4/5 filer). CIK 0001589602. Director at Theravance Biopharma, Inc. (TBPH) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Sep 23, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Smaldone Alsup Laurie has filed insider reports for
- Theravance Biopharma, Inc. (TBPH): Director
- ARVINAS, INC. (ARVN): Director
Smaldone Alsup Laurie
CIK: 0001589602
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)2 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Sep 23, 2026TBPH
Theravance Biopharma, Inc.
DispositionDirect75K shares- - Sep 23, 2026TBPH
Theravance Biopharma, Inc.
DispositionDirect6K shares- - Jun 24, 2026ARVN
ARVINAS, INC.
AwardDirect15.5K shares- - Jun 12, 2026TBPH
Theravance Biopharma, Inc.
AwardDirect6K shares- - Jun 25, 2025ARVN
ARVINAS, INC.
AwardDirect16K shares- - May 19, 2025TBPH
Theravance Biopharma, Inc.
AwardDirect10.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 23, 2026 |  TBPH Theravance Biopharma, Inc. | Disposition | 74,980 | - | $0 | Direct |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Disposition | 6,009 | - | $0 | Direct |
| Jun 24, 2026 |  ARVN ARVINAS, INC. | Award | 15,527 | - | $0 | Direct |
| Jun 12, 2026 | TBPH Theravance Biopharma, Inc. | Award | 6,009 | - | $0 | Direct |
| Jun 25, 2025 | ARVN ARVINAS, INC. | Award | 16,025 | - | - | Direct |
| May 19, 2025 | TBPH Theravance Biopharma, Inc. | Award | 10,649 | - | - | Direct |
1-6 of 6 transactions